Overdose deaths plummet by nearly 27% last year
SAVANNAH, Ga. (WSAV) – Overdose deaths plummeted in 2024, and the Centers for Disease Control (CDC) reported nearly 30,000 fewer lives lost compared to the previous year.
The nation is seeing the largest one-year decline recorded, according to the National Center for Health Statistics. The CDC reported Georgia saw a 22% drop in 2024.
Dr. Jay Goldstein, assistant medical director with Memorial Health said there are two key drivers for the overdose decline: awareness and education.
'There's just more a better awareness of the overdose potential and that you know that you have this reversal agent,' he said. 'So not only is it awareness for the consumer, the one that's actually using the drugs, but it's also an awareness for the firefighters, the paramedics, the police officers and then health care worker. so, we're able to get to those people more rapidly and save their lives with the with the reversal agent of Narcan.'
Goldstein said age range varies from teenagers to people in their 60's. He added most commonly it is 25 to 40-year-olds.
'There are fentanyl test strips out there, there's an awareness of where they're getting the drugs from, and it's a safer environment for those who are going to use that,' he said. 'They use it more safely also. But obviously the big thing for us is that we're trying to educate, especially the younger folks, to just never use. We feel like at this point we're seeing a drop off in the consumer and the addiction starting in the younger ages.'
He said locally, we are no stranger to trends and waves of drug infestation in the community. He told WSAV individuals still need to watch for the alteration of certain substances like drugs laced with fentanyl.
'We're actually trying to get a program up and running here at Memorial [Health] where a drug overdose might come in and we can actually start them on drugs that will prevent them from wanting to have drug overdoses such as like Suboxone…,' Goldstein said.
He added, 'I think mental health is a big aspect of things. I think social isolation, since we're coming out of the covid pandemic, has made a major difference and then also the ability to have treatment programs. so not only do we have treatment programs that people can go to, which had dried up and now they're getting more plentiful, but also the ability when they come into a clinic and they have an overdose, to try and attack them then and treat them there.'
Dr. Goldstein told WSAV while this is a sign of progress, there is still work to do.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
Robert F. Kennedy Jr. testifying during his Senate Committee on Health, Education, Labor and Pensions confirmation hearing on January 30, 2025 in Washington, DC Credit - Kevin Dietsch—Getty Images When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. Read More: What to Know About RFK Jr. Removing All Experts From CDC Vaccine Advisory Committee During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Read More: What's the Risk of Getting Long COVID in 2024? Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans. Contact us at letters@
Yahoo
33 minutes ago
- Yahoo
Slashing public health funding is a national security disaster in the making: Howard Dean
Federal and state government officials are axing public health funding—and justifying the cuts with appeals to fiscal this slash-and-burn approach is enormously shortsighted. Every dollar 'saved' now will cost us far more—in both dollars and lives—when the next health emergency inevitably know the toll an infectious disease outbreak can take. We just lived through one. COVID-19 killed over 1 million Americans and cost our economy trillions. Government-funded initiatives—such as federally backed research into mRNA vaccines and 'field team' deployments to local outbreaks—saved us from an even worse those very systems are being torn apart. This year alone, over $1.8 billion in NIH research funding has been terminated. The CDC's Healthcare Infection Control Practices Advisory Committee, which sets safety standards for hospitals, was just eliminated. The new federal budget could cut funding for the Department of Health and Human Services by over a it's not just pandemic preparedness systems suffering from mass layoffs and budget cuts. Institutions designed to protect Americans from foodborne illnesses, antibiotic-resistant infections, and bioterrorism are being gutted as put, this is a catastrophic mistake—one that doesn't merely threaten our health and economy, but also our national officials have long warned that pandemics, bioterrorism, and emerging infections are critical threats to U.S. stability. The Defense Department reported to Congress earlier this year on how it continually works to monitor and prevent infectious disease outbreaks, given that 'a pandemic could potentially impact every component of the Department's ability to perform its mission.'The National Security Commission on Emerging Biotechnology also warned about the growing threat posed by biowarfare in a recent report. Because America's biotech industry is falling behind China's, in part due to the government's dwindling support for research, we're increasingly vulnerable to bioweapon attacks from adversaries, the report United States spends billions to prepare for military threats we hope never materialize. Our leaders need to fund disease prevention efforts with the same urgency we give to tanks and missiles. As we learned from COVID, infectious diseases can cause more death and destruction than even the most powerful conventional also showed us that pandemic preparedness pays dividends. Countries that invested more in limiting disease risks, such as Iceland and New Zealand, experienced lower mortality rates. By contrast, America suffered because we had allowed our public health infrastructure to erode for cannot afford to repeat—or worse, deepen—that mistake. Policymakers can prevent that from happening by restoring funding for public health agencies and investing in resources, such as labs, vaccines, and rapid response teams, that serve as our first and last lines of public health funding may be politically expedient, but preventing infectious disease isn't a partisan issue. Pathogens don't check party affiliation, respect national borders, or stop at state have a solemn duty—both to current citizens and to future generations of Americans—to strengthen the public health institutions that keep us safe. It's time for our leaders to act like Dean is the former chair of the Democratic National Committee and former governor of Vermont. The opinions expressed in commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune. This story was originally featured on
Yahoo
33 minutes ago
- Yahoo
1.7 million air conditioners recalled for risk of mold. Is yours on the list?
Bad news for Floridians seeking to avoid the summer heat: your air conditioner may have been recalled for mold. Air conditioner company Midea announced it is recalling 1.7 million through-the-window air conditioners sold across the nation, according to a June 5 release from the U.S. Consumer Products Safety Commission (CPSC). At least 152 customers have reported mold in the units, and there have been 17 reports of consumers experiencing symptoms such as "respiratory infections, allergic reactions, coughing, sneezing and/or sore throats from mold exposure." "Pooled water in the air conditioners can fail to drain quickly enough," the CSPC said, "which can lead to mold growth. Mold exposure poses risks of respiratory issues or other infections to some consumers." Studies have shown that exposure to mold increases the chances of upper respiratory tract illnesses among ordinarily healthy people and can cause more serious problems for people with asthma or immune deficiencies, according to the Centers for Disease Prevention and Control (CDC). Early mold exposure may also be linked to development of astham in children, the CDC said. The units — U and U+ Window Air Conditioners made by Midea and sold under their name and others such as Comfort Aire, Danby, Frigidaire, Insignia, Keystone, LBG Products, Mr. Cool, Perfect Aire and Sea Breeze were sold at Costco, Menards, Home Depot, Lowes, Walmart, Best Buy, Amazon and other stores nationwide and online. Another 45,900 were sold in Canada. The air conditioners are white, about 22 inches wide, 13½ inches tall, and 19 inches deep. The units are available in 8,000, 10,000, and 12,000 BTU. Hot Florida summers: What's the best temperature to set your air conditioner thermostat? You can choose to have it repaired or get a prorated refund based on the purchase date or date of manufacture. If you choose repair, Midea will provide a technician to install a new drain plug or send consumers a repair kit that includes a new drain plug and bubble level, depending on the model. If you choose a refund, you have two options: Destroy it yourself: Unplug it, cut off the power cord, write "Recalled" ion the product, send a photo of it to Midea, and dispose of it in accordance with your local waste disposal requirements Send it back: You can opt to return the unit to Midea with a free pre-paid shipping label. The brand name is printed on the units and the model number can be found on a label on the front right side of the unit when facing the air conditioner. The following model numbers are included in the recall: Midea model numbers MAW08AV1QWT MAW08AV1QWT-C MAW08U1QWT MAW08U2QWT MAW08V1QWT MAW08V1QWT-S MAWO8V1QWT-T MAW08W1QWT MAW10U1QWT MAW10U2QWT MAW10V1QWT MAW10W1QWT MAW12AV1QWT MAW12AV1QWT-C MAW12U1QWT MAW12U2QWT MAW12V1QWT MAW12V1QWT-M MAW12V1QWT-S MAW12W1QWT MWO8MSWBA5RCM MW10MSWBA4RCM MW10MSWBA5RCM MW10MSWBA6RCM MW12MSWBA5RCM MW12MSWBA6RCM Comfort Air model numbers RXTS-101A RXTS-121A RXTS-81A Danby model numbers DAC080B6IWDB-6 DAC080B7IWDB-6 DAC100B6IWDB-6 Frigidaire model numbers GHWQ085WD1 GHWQ105WD1 GHWQ125WD1 Insignia model numbers NS-AC8WU3 NS-AC8WU3-C Keystone model numbers KSTAW08UA KSTAW10UA KSTAW12UA LBG Products model numbers QB-8K CO Mr. Cool model numbers MWUC08T115 MWUC10T115 MWUC12T115 Perfect Aire model numbers 1PACU10000 1PACU12000 1PACU8000 Sea Breeze model numbers MWAUQB-12CRFN8-BCN10 WAU310YREX WAU312YREX WAU38YREX You can also look up your model number and serial number at the Midea Recall webpage to see if your air conditioner is affected. This article originally appeared on The Daytona Beach News-Journal: Midea air conditioner recall: Mold reports prompt 1.7 million recall
